NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Michael Weinstein

J.P. Morgan



Recent Quotes

"Over the next couple of years we expect revenue and EPS growth to reaccelerate for JNJ."

— Michael Weinstein, J.P. Morgan (1/15/13)
more >

"In Q2/12, MDT's revenue growth accelerated to a three-year high."

— Michael Weinstein, J.P. Morgan (11/21/12)
more >

"In Q3/12, JNJ had its best sales performance since Q1/07."

— Michael Weinstein, J.P. Morgan (10/16/12)
more >

"QDEL is a name that small cap investors should own."

— Michael Weinstein, William Blair (9/18/12)
more >

"The U.S. adoption of EW's Sapien is occurring at a pace notably ahead of expectations."

— Michael Weinstein, J.P. Morgan (7/20/12)
more >

"A favorable outcome is ultimately likely for FDA approval of EW's Sapien expansion."

— Michael Weinstein, J.P. Morgan (6/11/12)
more >

"EW has a lot of growth in front of it."

— Michael Weinstein, J.P. Morgan (4/13/12)
more >

"EW could post significant upside from its SAPIEN U.S. launch."

— Michael Weinstein, J.P. Morgan (3/26/12)
more >



Due to permission requirements, not all quotes are shown.